argenx SE

Equities

ARGX

NL0010832176

Market Closed - Euronext Bruxelles Other stock markets 18:35:10 12/06/2025 +03			5-day change	1st Jan Change
505.80 ^EUR	-0.12%		-0.98%	-15.70%

06-11	Argenx Says Vyvgart Improved Muscle Strength in Phase 2 Myositis Trial	MT
06-11	Argenx SE Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease	CI

Argenx SE Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08:40 AM

Published on 10/06/2025 at 17:05, updated on 10/06/2025 at 19:05

Presenter Speech
Rajan Sharma (Analysts)

Good morning, everyone. My name is Rajan Sharma. I cover European pharma and biotech here at Goldman Sachs. I'm very pleased to have with us this morning, Karl

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about argenx SE

Argenx Says Vyvgart Improved Muscle Strength in Phase 2 Myositis Trial	06-11	MT
Argenx SE Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease	06-11	CI
Argenx Presents New Data Highlighting Phase 2 Results In Myositis And Sjogren'S Disease	06-11	RE
Argenx SE Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08:40 AM	06-10
Scholar Rock Holding Corporation Announces Appointment of Rebecca Mcleod as Chief Brand Officer	06-02	CI
European Equities Close Lower in Wednesday Trading; French GDP Edges Higher	05-28	MT
Argenx Set to See Further Growth Due to Vyvgart Momentum, Pipeline Expansion, Wedbush Says	05-28	MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	05-21	MT
Argenx SE Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04:20 PM	05-14
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading	05-13	MT
Baird Upgrades argenx to Outperform From Neutral, Price Target is $680	05-13	MT
Donald Trump deals another blow to Big Pharma	05-12
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	05-08	MT
Sector Update: Health Care Stocks Decline Pre-Bell Thursday	05-08	MT
Argenx SE, Q1 2025 Earnings Call, May 08, 2025	05-08
Argenx Reports Q1 Earnings, Higher Operating Income; Shares Down Pre-Bell	05-08	MT
U.S. Futures, European Stocks Rise	05-08	DJ
Immunology Company argenx Swings to Profit in Q1; Net Sales Rise	05-08	MT
Argenx Q1 Total Operating Income At $807.37 Mln	05-08	RE
Argenx SE Reports Earnings Results for the First Quarter Ended March 31, 2025	05-08	CI
On the stockmarket, the pharmaceutical industry is wary of FDA's new strongman	05-07
US FDA approves J&J's immune disorder drug	04-30	RE
European Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday Trading	04-30	MT
The bulls are hanging on!	04-28
Halozyme Announces Argenx Received Positive CHMP Opinion For Vyvgart (Efgartigimod Alfa) Subcutaneous Injection With Enhanze For CIDP	04-28	RE